Results 1 to 10 of about 104,235 (402)

Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference

open access: yesGastroenterology, 2018
BACKGROUND & AIMS Over the last decade, clinical experiences and research studies raised concerns regarding use of proton pump inhibitors (PPIs) as part of the diagnostic strategy for eosinophilic esophagitis (EoE). We aimed to clarify the use of PPIs in
Evan Dellon   +2 more
exaly   +2 more sources

Case report: Lichenoid esophagitis revealing an HIV infection [PDF]

open access: goldFrontiers in Medicine
Esophageal lichen planus is an underrecognized manifestation of lichen planus. It is typically diagnosed based on characteristic endoscopic findings, such as hyperkeratosis, trachealization, denudation and/or stenosis, along with the presence of a ...
Jasmin Marschner   +4 more
doaj   +2 more sources

Esophageal Lichen Planus—Contemporary Insights and Emerging Trends [PDF]

open access: yesBiomedicines
Background: Lichen planus (LP) is a common inflammatory disease affecting skin, mucous membranes, hairs, and nails, with an unpredictable course involving remissions and relapses.
Wolfgang Kreisel   +5 more
doaj   +2 more sources

Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis.

open access: yesNew England Journal of Medicine, 2022
BACKGROUND Dupilumab, a fully human monoclonal antibody, blocks interleukin-4 and interleukin-13 signaling, which have key roles in eosinophilic esophagitis.
E. Dellon   +29 more
semanticscholar   +1 more source

Histomorphological and Immunophenotypic Features of Pill-Induced Esophagitis. [PDF]

open access: yesPLoS ONE, 2015
The aim of this study was to investigate histomorphological and immunophenotypic features in pill-induced esophagitis. We comparatively evaluated the histomorphological, immunophenotypic features of pill-induced esophagitis vs.
Ji Won Kim   +7 more
doaj   +1 more source

VONOPRAZAN VERSUS LANSOPRAZOLE FOR HEALING AND MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS: A RANDOMIZED TRIAL.

open access: yesGastroenterology, 2022
BACKGROUND & AIMS For decades, proton pump inhibitors (PPIs) have been the mainstay of treatment for erosive esophagitis. The potassium-competitive acid blocker vonoprazan provides more potent acid inhibition than PPIs but data on its efficacy for ...
L. Laine   +6 more
semanticscholar   +1 more source

Atypical Presentation of Esophageal Squamous Cell Carcinoma Masquerading as Diffuse Severe Esophagitis

open access: yesCase Reports in Gastroenterology, 2021
Esophagitis is described as an inflammation of the esophagus and can result from multiple etiologies. Esophageal squamous cell carcinoma (ESCC), presenting as diffuse esophagitis in the absence of a mass or lesion, is rare. We present a case of a 61-year-
Hafsa Abbas   +4 more
doaj   +1 more source

Eosinophilic Esophagitis.

open access: yesNew England Journal of Medicine, 2021
Eosinophilic esophagitis (also known as EoE) is a disease characterized by the presence of a large number of a special type of white blood cell, the eosinophil, that can cause inflammation in the esophagus.
G. Furuta, D. Katzka
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy